Discovery Finds How Ovarian Cancer Disables Immune Cells

submited by
Style Pass
2024-11-02 21:00:05

This confocal micrograph shows how two proteins, TAGLN2 (green) and FABP5 (red), are found together (yellow) on the surfaces of T cells, enabling the cells to pick up lipids that are their energy source . Credit: Cubillos-Ruiz Lab

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack—blocking the energy supply T cells depend on. The study, published Oct. 23 in Nature, points toward a promising new immunotherapy approach for ovarian cancer, which is notoriously aggressive and hard to treat.

A significant obstacle in treating ovarian cancer is the tumor microenvironment—the complex ecosystem of cells, molecules and blood vessels that shields cancer cells from the immune system. Within this hostile environment, T cells lose their ability to take up the lipid (fat) molecules, which are necessary for energy to mount an effective attack.

“T cells rely on lipids as fuel, burning them in their mitochondria to power their fight against pathogens and tumors,” explained senior author, Dr. Juan Cubillos-Ruiz, The William J. Ledger, M.D., Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology at Weill Cornell Medicine. “However, the molecular mechanisms that govern this critical energy supply are still not well understood.”

Leave a Comment